May 2017 MODEL CLINICAL TRIAL AGREEMENT FOR PHARMACEUTICAL INDUSTRY SPONSORED, PHASE [II or III] MULTI-SITE DRUG TRIALSMay 26th, 2022
FiledMay 26th, 2022Institution is an organisation engaged in the diagnosis, treatment and prevention of disease and/or clinical research for the improvement of healthcare, and has the facilities and Study Personnel necessary to conduct the Clinical Trial.